About Tosoh India Pvt. Ltd. 

Tosoh's Bioscience Division, operating under the globally unified brand Tosoh Bioscience, has emerged as a technology leader in the field of automated immunoassay analyzers, HPLC based automated systems for diabetes and thalassemia screening as well as products for allergy diagnosis. Harnessing deep scientific understanding, research and manufacturing ability of HPLC resins as well as columns has made Tosoh Bioscience a forerunner in the industry.

Tosoh Corporation’s entry in the Indian subcontinent transpired in April 2015 with the acquisition of Lilac Medicare (P) Ltd., a leading Indian clinical diagnostic company. Renamed Tosoh India Pvt. Ltd. (formerly Lilac Medicare (P) Ltd.), the company has not only retained Lilac’s dominating presence in the microwell Elisa & Chemiluminescence based semi-automated immunoassay business but has also reinforced its presence in the clinical diagnostic market through Tosoh’s pioneering range of advanced Japanese technology based automated immunoassay platforms and HPLC based systems for diabetes and thalassemia screening.

With a proven reputation, innovative path breaking technology and a deep commitment towards addressing customer needs, Tosoh India Pvt. Ltd. is poised for redefining the future of clinical diagnostics not only in India but also in the neighboring countries of Nepal, Bangladesh and Sri Lanka.